Ticker
TARSCompany Name
TARSUS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 474.43M | 5.26 | $ 90.25M |
3/31/2025 | $ 480.77M | 5.57 | $ 86.31M |
12/31/2024 | $ 356.7M | 4.42 | $ 80.61M |
9/30/2024 | $ 357.12M | 5.42 | $ 65.87M |
6/30/2024 | $ 362.59M | 7.03 | $ 51.57M |
3/31/2024 | $ 340.72M | 8.01 | $ 42.53M |
12/31/2023 | $ 256.13M | 6.93 | $ 36.94M |
9/30/2023 | $ 259.28M | 11.15 | $ 23.25M |
6/30/2023 | $ 183.48M | 12.43 | $ 14.77M |
3/31/2023 | $ 208.65M | 15.74 | $ 13.26M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for TARSUS PHARMACEUTICALS INC is calculated as follows: AssetsC [ $ 89.07M ] / LiabilitesC [ $ 6.14M ]
(=) Current Ratio [ 14.5 ]
Minimum
Dec 31, 2024
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |